In VitroActivity of Vinorelbine on Human Leukemia Cells
Authors:
- B. BartolozziBBB. Bartolozzi
- I. BanchelliIBI. Banchelli
- A. Degli InnocentiAIA. Degli Innocenti
- O. NocentiniONO. Nocentini
- P.A. BernabeiPBP.A. Bernabei
- 1 January 2001
- journal article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 13 (3) , 309-315
Abstract
Vinorelbine (VNR) is a semi-synthetic Vinca rosea alkaloid that has been employed both as a single agent and in combination, and has shown significant antitumor activity. As little is known about VNR activity on human leukemia, we studied its in vitro cytotoxic effect on human leukemia cell lines (FLG 29.1, HL60, K562, Balm 4, CEM and Daudi) and on fresh leukemia cells from 28 patients: 2 acute myeloid leukemia (AML); 3 chronic myeloid leukemia in blastic phase (CML-BP); 5 acute lymphoblastic leukemia (ALL); 18 B-chronic lymphatic leukemia (B-CLL), employing the colorimetric INT assay and determining the IC50. We observed that VNR exerts its cytotoxic activity on leukemic cell lines in a dose-dependent fashion. The lymphoid cell lines appear more sensitive than the myeloid ones to the VNR-dependent growth inhibition. A similar pattern was noticed for leukemia cells in primary cultures. VNR is not effective on CML-BP cells, shows variable activity on the AML and ALL cells and is very effective against B-CLL cells. VNR inhibited the growth of fresh B-CLL cells from 15 of 18 patients, the IC50 doses ranging from 4 ng/ml to 83 microg/ml (doses coinciding with the plasma levels obtained in clinics). These observations strongly suggest that VNR could be useful in clinics for the treatment of B-CLL.Keywords
This publication has 21 references indexed in Scilit:
- Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian CancerGynecologic Oncology, 1999
- Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's diseaseBritish Journal of Haematology, 1998
- Vinorelbine: A New Promising Drug in Hodgkin's DiseaseLeukemia & Lymphoma, 1996
- The role of vindesine in oncology—recommendations after 10 yearsʼ experienceAnti-Cancer Drugs, 1995
- Kinetic Analysis of Combination Effect of Navelbine (KW-2307) with Cisplatin against Human Lung Adenocarcinoma PC-12 Cells in CultureJapanese Journal of Cancer Research, 1992
- Antiproliferative activity of vinorelbine (Navelbine) against six human melanoma cell linesJournal of Cancer Research and Clinical Oncology, 1992
- Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubulesInternational Journal of Cancer, 1990
- In vitro chemosensitivity testing of leukemic cells: Prediction of response to chemotherapy in patients with acute non‐lymphocytic leukemiaHematological Oncology, 1989
- In vitro chemosensitivity testing of leukemic cells: Development of a semiautomated colorimetric assayHematological Oncology, 1989
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977